Archive: 28/09/2015
News from the field of fear and anxiety research
The targeted modulation of gene activity and cellular signaling pathways could provide a new approach to the treatment of fear and anxiety states according to the recent findings of a project sponsored by the Austrian Science ...
Sep 28, 2015
Atezolizumab set to change refractory lung cancer treatment
Atezolizumab is set to substantially change treatment strategies for patients with refractory lung cancer, according to Dr Martin Reck, Chief Oncology Physician in the Department of Thoracic Oncology, Hospital Grosshansdorf, ...
Sep 28, 2015
First UK Biobank genetic study reveals new associations with lung disease and smoking behavior
New research published in The Lancet Respiratory Medicine and presented at this year's European Respiratory Society (ERS) meeting in Amsterdam presents the first analyses of genetic data from the UK Biobank that reveal new ...
Sep 28, 2015
Drug combination improves progression-free survival in melanoma patients
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. ...
Sep 28, 2015
Post diagnosis aspirin improves survival in all gastrointestinal cancers
Vienna, Austria: Aspirin improves survival in patients with tumours situated throughout the gastrointestinal (GI) tract, results from a large study in The Netherlands show. This is the first time that survival data from patients ...
Sep 28, 2015